References: European Medicines Agency (EMA) (2024): OBGEMSA, INN-Vibegron - Summary of Product Characteristics
Why your prescription purpose doesnt disqualify you: The injury is the same whether you took the drug for diabetes or weight loss The warnings were inadequate for both approved uses The mechanism is identical regardless of indication The failure to warn affected all patients, not just one category In fact, diabetes patients may have stronger arguments: You needed the medication for a serious health condition You had fewer alternatives available The risk-benefit calculation was different You were a captive market with less choice Your claim will focus on: Whether you were adequately informed of gastroparesis risk Whether the severity and potential permanence were disclosed Whether you would have chosen differently if properly warned The damages you suffered as a result Q: What if I took multiple GLP-1 drugs over time
These programs typically require proof of a Medicaid denial letter, documentation of household income, and a prescription from a licensed provider
Do not use after the expiry date shown on the packaging
The addition of NAD (5000mg) enhances cellular energy production and supports DNA repair mechanisms
Health savings accounts (HSA), which allow for squirreling away pre-tax dollars that can be used to pay for health and medical expenses not covered by insurance, can be a very valuable tool in your financial portfolio
